OneMedNet Reports 111% Revenue Growth Amidst Going Concern Warning and Internal Control Weaknesses

summarizeSummary

OneMedNet Corp reported a 111% revenue increase for FY2025, driven by its iRWD platform, but disclosed substantial doubt about its ability to continue as a going concern and identified material weaknesses in internal financial controls.

check_boxKey Events

• Going Concern Warning Issued

  Both management and the independent auditor expressed substantial doubt about the company's ability to continue as a going concern, citing recurring net losses and insufficient cash ($0.6 million as of Dec 31, 2025) to fund operations for the next 12 months.

• Material Weaknesses in Internal Controls Identified

  Management concluded that internal controls over financial reporting were ineffective as of December 31, 2025, due to material weaknesses related to user access/segregation of duties, lack of formalized control, and errors in revenue recognition.

• Significant Revenue Growth Driven by iRWD Platform

  Total revenue increased by 111% to $1.359 million for FY2025, primarily due to a 329% increase in data delivery revenue from the iRWD platform, despite the decommissioning of the legacy BEAM platform in May 2025.

• Substantial Liability Reduction Through Dilutive Financing

  The company reduced total liabilities by $11.9 million (62%) through conversions of PIPE Notes and related party loans, and settlement of deferred underwriter fees. This was supported by private placements and SEPA advances totaling $4.2 million in 2025, leading to significant share dilution.

auto_awesomeAnalysis

OneMedNet Corp's annual report reveals a company in a precarious financial position, despite significant revenue growth. The explicit 'going concern' warning from both management and auditors, coupled with identified material weaknesses in internal controls, signals fundamental operational and financial risks. While the 111% revenue increase and substantial debt reduction are positive developments, they are overshadowed by the ongoing need for dilutive financing and the underlying profitability challenges. Investors should be aware of the high risk associated with the company's ability to sustain operations and achieve profitability, despite its strategic shift towards the high-growth iRWD platform.